Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

India · Delayed Price · Currency is INR

165.01

-8.33 (-4.81%)

Mar 9, 2026, 2:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	2.69B	2.09B	2.37B	2.18B	1.88B
Pharmaceuticals Growth	28.76%	-11.83%	8.79%	15.77%	18.53%
Total	2.69B	2.09B	2.37B	2.18B	1.88B
Total Growth	28.76%	-11.83%	8.79%	15.77%	18.53%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Apr '17 Apr 1, 2017	Mar '16 Mar 31, 2016
India	2.65B	2.04B	2.31B	2.12B	-
India Growth	29.98%	-11.74%	8.97%	-	-
Rest of The World	34.96M	46.61M	55.28M	54.26M	-
Rest of The World Growth	-24.99%	-15.68%	1.88%	-	-
Total	2.69B	2.09B	2.37B	2.18B	-
Total Growth	28.76%	-11.83%	8.79%	-	-

Source: S&P Global Market Intelligence.